Clifford Chance leads on Cinven’s £2.3bn pharma sale to Sullivan client Concordia
A host of Canadian, US and UK firms have all won roles on Cinven’s £2.3bn sale of London-based Amdipharm Mercury Company (AmCo) to Toronto’s Concordia Healthcare. Clifford Chance advised longstanding client Cinven with a team led by global private equity partner Jonny Myers. Partner Alastair Mordaunt advised on antitrust matters, while fellow partners Rod McGillivray […]